Literature DB >> 11054565

p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas.

A Tikoo1, S Czekay, C Viars, S White, J K Heath, K Arden, H Maruta.   

Abstract

To date, two distinct genes coding for Ras GAP-binding phosphoproteins of 190kDa, p190-A and p190-B, have been cloned from mammalian cells. Rat p190-A of 1513 amino acids shares 50% sequence identity with human p190-B of 1499 amino acids. We have previously demonstrated, using rat p190-A cDNA, that full-length p190-A is a tumor suppressor, reversing v-Ha-Ras-induced malignancy of NIH 3T3 cells through both the N-terminal GTPase (residues 1-251) and the C-terminal Rho GAP (residues 1168-1441) domains. Here we report the cloning of the full-length human p190-A cDNA and its first exon covering more than 80% of this protein, as well as its chromosomal mapping. Human p190-A encodes a protein of 1514 amino acids, and shares overall 97% sequence identity with rat p190-A. Like the p190-B exon, the first exon of p190-A is extremely large (3.7 kb in length), encoding both the GTPase and middle domains (residues 1-1228), but not the remaining GAP domain, suggesting a high conservation of genomic structure between two p190 genes. Using a well characterized monochromosome somatic cell hybrid panel, fluorescent in situ hybridization (FISH) and other complementary approaches, we have mapped the p190-A gene between the markers D19S241E and STD (500 kb region) of human chromosome 19q13.3. Interestingly, this chromosomal region is known to be rearranged in a variety of human solid tumors including pancreatic carcinomas and gliomas. Moreover, at least 40% glioblastoma/astrocytoma cases with breakpoints in this region were previously reported to show loss of the chromosomal region encompassing p190-A, suggesting the possibility that loss or mutations of this gene might be in part responsible for the development of these tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054565     DOI: 10.1016/s0378-1119(00)00387-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  23 in total

Review 1.  Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.

Authors:  Aurélien Bidaud-Meynard; Fabien Binamé; Valérie Lagrée; Violaine Moreau
Journal:  Small GTPases       Date:  2017-03-13

2.  Low Frequent Mutation of ARHGAP35, a Candidate Tumor Suppressor Gene, in Gastric and Colorectal Cancers.

Authors:  Eun Ji Choi; Min Sung Kim; Sang Yong Song; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2017-02-07       Impact factor: 3.201

3.  P190A RhoGAP is required for mammary gland development.

Authors:  B M Heckman-Stoddard; T Vargo-Gogola; M P Herrick; A P Visbal; M T Lewis; J Settleman; J M Rosen
Journal:  Dev Biol       Date:  2011-09-16       Impact factor: 3.582

4.  The Tumor Suppressor, p190RhoGAP, Differentially Initiates Apoptosis and Confers Docetaxel Sensitivity to Breast Cancer Cells.

Authors:  Kirsten Ludwig; Sarah J Parsons
Journal:  Genes Cancer       Date:  2011-01

5.  Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA.

Authors:  Isabel Molina-Ortiz; Rubén A Bartolomé; Pablo Hernández-Varas; Georgina P Colo; Joaquin Teixidó
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

Review 6.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

7.  Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging.

Authors:  Fredrik K Johansson; Josefin Brodd; Charlotta Eklöf; Maria Ferletta; Göran Hesselager; Carl-Fredrik Tiger; Lene Uhrbom; Bengt Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

8.  A common phosphotyrosine signature for the Bcr-Abl kinase.

Authors:  Valerie L Goss; Kimberly A Lee; Albrecht Moritz; Julie Nardone; Erik J Spek; Joan MacNeill; John Rush; Michael J Comb; Roberto D Polakiewicz
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

9.  Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis.

Authors:  Linda Sequeira; Cara W Dubyk; Tracy A Riesenberger; Carlton R Cooper; Kenneth L van Golen
Journal:  Clin Exp Metastasis       Date:  2008-05-07       Impact factor: 5.150

10.  Opposing roles of p190RhoGAP and Ect2 RhoGEF in regulating cytokinesis.

Authors:  Masahito Mikawa; Ling Su; Sarah J Parsons
Journal:  Cell Cycle       Date:  2008-07-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.